Novel RNA Modality for Translation in Eukaryotic Cells

Exclusively Licensed

Disclosed are methods and constructs for engineering circular RNA Disclosed is a vector for making circular RNA, said vector comprising the following elements operably connected to each other and arranged in the following sequence: a) a 5′ homology arm, b) a 3′ group I intron fragment containing a 3′ splice site dinucleotide, c) an optional 5′ spacer sequence, d) a protein coding or noncoding region, e) an optional 3′ spacer sequence, f) a 5′ Group I intron fragment containing a 5′ splice site dinucleotide, and g) a 3′ homology arm. This vector allows production of a circular RNA that is translatable or biologically active inside eukaryotic cells. In one embodiment, the vector can comprise the 5′ spacer sequence, but not the 3′ spacer sequence. In yet another embodiment, the vector can also comprise the 3′ spacer sequence, but not the 5′ spacer sequence.

Researchers

Daniel Anderson / Robert Wesselhoeft / Piotr Kowalski

Departments: Department of Chemical Engineering
Technology Areas: Biotechnology: Biomanufacturing, DNA & RNA Editing, Synthetic Biology / Therapeutics: Nucleic Acids
Impact Areas: Healthy Living

  • circular rna for translation in eukaryotic cells
    China | Published application
  • circular rna for translation in eukaryotic cells
    United States of America | Granted | 11,981,909
  • circular rna for translation in eukaryotic cells
    Japan | Published application
  • circular rna for translation in eukaryotic cells
    Australia | Granted | 2,019,280,583
  • circular rna for translation in eukaryotic cells
    Canada | Published application
  • circular rna for translation in eukaryotic cells
    European Patent Convention | Published application
  • circular rna for translation in eukaryotic cells
    Korea (south) | Published application
  • circular rna for translation in eukaryotic cells
    China | Granted | 112,399,860
  • circular rna for translation in eukaryotic cells
    Mexico | Published application
  • circular rna for translation in eukaryotic cells
    Israel | Pending
  • circular rna for translation in eukaryotic cells
    Brazil | Published application
  • circular rna for translation in eukaryotic cells
    Singapore | Pending
  • circular rna for translation in eukaryotic cells
    Israel | Pending
  • circular rna for translation in eukaryotic cells
    United States of America | Granted | 11,203,767
  • circular rna for translation in eukaryotic cells
    Hong Kong | Granted | 40,038,458
  • circular rna for translation in eukaryotic cells
    United States of America | Granted | 11,447,796
  • novel rna modality for translation in eukaryotic cells
    United States of America | Granted | 11,845,950
  • circular rna for translation in eukaryotic cells
    Hong Kong | Published application
  • circular rna for translation in eukaryotic cells
    United States of America | Granted | 11,352,640
  • circular rna for translation in eukaryotic cells
    Australia | Pending
  • circular rna for translation in eukaryotic cells
    United States of America | Published application
  • circular rna for translation in eukaryotic cells
    United States of America | Granted | 11,352,641
  • circular rna for translation in eukaryotic cells
    United States of America | Published application

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

More Technologies